S

SparingVision

42 employees

SparingVision is a biotechnology company developing genomic medicines for the treatment of blinding inherited retinal diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Life Science

Date founded

2016

Funding rounds raised

Total raised

$75M

from 8 investors over 8 rounds

S

SparingVision raised $75M on September 14, 2022

Investors: RD Fund, UPMC Enterprises, Ysios Capital and JEITO

S

SparingVision raised undisclosed on October 13, 2021

Investors: Intellia Therapeutics, Inc.

S

SparingVision raised $53M on October 21, 2020

Investors: UPMC Enterprises, JEITO and Ysios Capital

FAQ